A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh
- 1 March 1980
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 21 (3) , 207-215
- https://doi.org/10.1016/0010-7824(80)90001-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intraepithelial cervical neoplasia in women using intrauterine devices and long-acting injectable progestogens as contraceptivesAmerican Journal of Obstetrics and Gynecology, 1974
- Use-effectiveness of six-month injections of DMPA as a contraceptiveAmerican Journal of Obstetrics and Gynecology, 1974
- Depot-medroxyprogesterone acetate as a contraceptive agent: Return of fertility after discontinuation of useContraception, 1973
- Long-term administration of progesterone to the female beagle dogToxicology and Applied Pharmacology, 1973
- Incidence of breast nodules in women receiving multiple doses of medroxyprogesterone acetateJournal of Biosocial Science, 1973
- The long-term use of injectable norethisterone enanthate as a contraceptiveContraception, 1972
- A Comparison of the Long‐Acting Contraceptive Agents Norethisterone Oenanthate and Medroxyprogesterone AcetateAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1971
- Contraception with a Six‐Monthly Injection of Progestogen: Part 1. Effects on Blood Pressure, Body Weight and Uterine Bleeding Pattern, Side‐Effects, Efficacy, and AcceptabilityAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1971
- Injected Progestogen and LactationBMJ, 1971
- Pituitary-Adrenal Function in Ten Patients Receiving Medroxyprogesterone Acetate for True Precocious PubertyJournal of Clinical Endocrinology & Metabolism, 1970